hVEGF-IN-1
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-101931-1 mg |
| CAS # | 1637443-98-1 |
| Pricing | 1 mg, USD $150.0 |
| Biological Activity | hVEGF-IN-1, a quinazoline derivative, could specifically bind to the G-rich sequence in the internal ribosome entry site A (IRES-A) and destabilize the G-quadruplex structure. hVEGF-IN-1 binds to the IRES-A (WT) with a Kd of 0.928 μM in SPR experiments. hVEGF-IN-1 could hinder tumor cells migration and repress tumor growth by decreasing VEGF-A protein expression[1]. |
| Purity | 98.31% |
| MWt | 581.75 |
| Formula | C₃₄H₄₃N₇O₂ |